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Since the Institute of Medicine (now National Academies of Science, Engineering, and Medicine) report of 
1999,1 patient safety work in inpatient settings, surgery, emergency department, devices, and infection 
control has been advanced. Many studies have been done to identify hazards and contributing factors 
(e.g., organizational culture, inter-professional communication). And, many improvements have been 
implemented to reduce those hazards.2 A unique and distinct component of patient safety as a whole is 
medication safety. But, unlike many advances in inpatient medical environments, medication safety 
(particularly in the outpatient setting) has lagged behind, in part because the medication use process is 
diametrically different in inpatient and outpatient settings. In the outpatient setting, patients and 
caregivers must assume significant responsibility in their own medication administration; therefore, the 
hazards that lead to medication errors are multi-dimensional and difficult to quantify.   
Medication errors are among the most common incidents leading to adverse events in patient care and 
result in considerable human suffering and unnecessary deaths. As an estimate, one medication error 
occurs per hospitalized patient daily, and medication errors cost tens of billions of US dollars each year. 
Medication errors can occur in any healthcare setting during various stages of the medication use process, 
including prescribing, dispensing, administering and using medicines. It has been well established that the 
majority of the errors would be preventable and commonly provoked by weaknesses in organizational 
systems and processes (i.e., system factors).  
Fifteen years after the first IOM report To Err is Human, the National Patient Safety Foundation made 
eight recommendations for achieving total system safety, including creating a common set of safety 
metrics that reflect meaningful outcomes, establishing and sustaining a culture of safety, centralizing 
oversight of patient safety at the national level, improving the safety of information technology, and 
supporting patients, families, and the health care workforce.3  
In 2017, The World Health Organization (WHO) launched the Global Patient Safety Challenge on 
Medication Safety with a vision/goal to reduce the level of severe, avoidable harm related to medications 
by 50% over the next five years throughout the world.4 The specific objectives of the challenge include: 1) 
To assess the scope and nature of avoidable harm and strengthen the monitoring systems to detect and 
track this harm; 2) To create a framework for action aimed at patients, health professionals and policy 
makers, to facilitate improvements in ordering, prescribing, preparation, dispensing, administration and 
monitoring practices, which can be adopted and adapted locally; 3) To develop guidance, materials, 
technologies and tools to support the setting up of safer medication use systems for  reducing medication 
errors;  4) To engage key stakeholders, partners and industry to raise awareness of the problem and 
actively pursue efforts to improve medication safety; and 5) To empower families and their caregivers to 
become actively involved and engaged in treatment or care decisions, ask questions, spot errors and 
effectively manage their medications.  
Medication errors and unsafe medication practices are a global public health issue. Despite myriad 
initiatives undertaken internationally, nationally and locally to improve patient safety, there is still much 
to do in this area. As a discipline, medication-focused safety science is in its adolescence, and is still 
maturing and coalescing into a cohesive body of evidence-based, generalizable, and scalable research.  
As a result, Research in Social and Administrative Pharmacy issued a call for papers toward a special 
issue on medication safety.  It was believed that a special issue could engage pharmacists, researchers, 
and policy makers in this important dialogue of how to move forward together in a thoughtful way.  It is 
hoped that the readers of this special issue come away with an appreciation of the work that has already 
been done, but to heighten their awareness that much work is still to come, and that the need to 
understand how medication errors take place, and to develop and evaluate creative and evidence-based 
interventions that will improve the safety of the patients that we care for. 
Within this special issue will be found fourteen manuscripts – one editorial, five commentaries and nine 
original research articles. This issue leads with an editorial about Dr. Maria Cordina from the World 
Health Organization, highlighting the urgency to prepare the health workforce to challenging task of 
improving medication safety.5 It then provides an overview and cross-section of patient safety research 
before and immediately after the launch of WHO Global Patient Safety Challenge. You will find original 
research from a diverse group of countries, representing different health systems and policies, from 
North America to Europe to China. Medication safety research is approached from both quantitative 
methods with large population level data, as well as a deep dive into context specific details using 
qualitative and mixed methods.   
All commentaries raise the need for joint actions to achieve the ambitious aim of WHO Global Patient 
Safety Challenge to reduce medication errors and medication related harm by 50% in the following 5 years 
throughout the world. The Bader et al., Smith et al. and Hong et al. provides community pharmacy 
perspective to this themed issue.6-8 They highlight that pharmacists have a key role in preventing and 
decreasing risks in medicines use, and thus, mitigating the global challenge of patient safety.  Additionally, 
the Bader et al. describes how the medication safety is a strategic priority of International Pharmaceutical 
Federation (FIP), and how FIP have and will contribute to this challenge in close collaboration with the 
World Health Organization (WHO). Whereas, Smith presents a novel framework for how to move forward 
and to promote primary care medication use and safety as part of preventative care or chronic care 
management initiatives. Tetteh provides perspectives from high and low-income countries, and upraises 
the need to take account national needs and challenges when outlining the implementation strategies of 
Global Patient Safety Challenge in different countries.9 For example in US, as described by Abraham et al., 
misuse of prescription opioids and associated negative health outcomes is a leading public health crisis 
among adolescents.10  
Four original research articles, with work contributed from China, Finland, and the United States, describe 
the important role of medication error reporting systems. Chen et al. describes the effect of 
implementation of a Medication Error Monitoring System at one hospital in China on the number and 
types of medication errors reported by physicians and pharmacists.11 Lester et al. and Darbishire et al. 
described medication error reporting in community pharmacy settings in the United States.12-13 Lester et 
al. applied text analysis to the narratives submitted with medication error reports in order to expand on 
information provided in the structured sections of reports. Darbishire et al. engaged second professional 
year pharmacy students to collect data on medication error reporting as part of their experiential learning 
experiences at community pharmacies. These papers provide insights into novel strategies for collecting 
data about medication errors and reporting practices. However, Holmstrom et al. demonstrate that more 
work is needed to ensure consistency in error classification among professionals submitting error 
reports.14 
Finally, four original research articles describe tools and strategies for error prevention in Australia, 
Canada, Finland, and the United States. Schepel et al. documents how clinical pharmacy services in Finnish 
hospitals changed from 2011 to 2016 in response to national patient safety priorities.15 Also focused on 
institutional practice, Marwitz et al. explores IV smart pump alert overrides for both high alert and non-
high alert medications, determining that work is needed to reduce alert fatigue for smart pump users.16 
Barker et al. and Wood et al. present data pertaining to community pharmacy practice.17-18 Barker et al. 
interviewed Canadian community pharmacists to identify barriers to use of patient safety information 
sources. Wood et al. describes the implementation of clinical decision support tool for pharmacists and 
also found some barriers to use. 
Patient safety science is making significant advances toward reducing medication errors and improving 
health care quality. Indeed, the manuscripts presented in this issue exemplify the efforts that are being 
made globally. But progress continues to be slow, in part because the patient safety challenge is multi-
dimensional and multi-faceted.  It is our hope that this issue will add to the urgent need for greater 
investment in patient safety, and specifically encourage discussion and research to follow implementation 
and outcomes of medication safety initiatives. 
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